The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
These new findings indicate that NAD+ supplementation holds promise as a therapeutic strategy for enhancing endothelial function in older adults with PAD and for preventing or delaying vascular complications, including cognitive impairment
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
NEW STUDY: 8 patients taking 1000 mg/d nicotinamide riboside (NR) for a month saw improvements in brain vasculature & cognition.